{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:33:17Z","timestamp":1761561197522},"reference-count":45,"publisher":"Elsevier BV","issue":"50","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.vaccine.2007.09.063","type":"journal-article","created":{"date-parts":[[2007,11,6]],"date-time":"2007-11-06T12:20:25Z","timestamp":1194351625000},"page":"8410-8419","source":"Crossref","is-referenced-by-count":13,"title":["Catalytically inactive anthrax toxin(s) are potential prophylactic agents"],"prefix":"10.1016","volume":"25","author":[{"given":"Megha","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheeba","family":"Alam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh","family":"Bhatnagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.09.063_bib1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.cellbio.19.111301.140655","article-title":"Anthrax toxin","volume":"19","author":"Collier","year":"2003","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"5364","key":"10.1016\/j.vaccine.2007.09.063_bib2","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1126\/science.280.5364.734","article-title":"Proteolytic inactivation of MAP-kinase\u2013kinase by anthrax lethal factor","volume":"280","author":"Duesbery","year":"1998","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.vaccine.2007.09.063_bib3","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1006\/bbrc.1998.9040","article-title":"Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine\/threonine phosphorylation of MAPKs in cultured macrophages","volume":"248","author":"Vitale","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"10.1016\/j.vaccine.2007.09.063_bib4","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1073\/pnas.79.10.3162","article-title":"Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells","volume":"79","author":"Leppla","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"10.1016\/j.vaccine.2007.09.063_bib5","doi-asserted-by":"crossref","first-page":"7006","DOI":"10.1128\/IAI.73.10.7006-7010.2005","article-title":"Pathophysiological manifestations in mice exposed to anthrax lethal toxin","volume":"73","author":"Culley","year":"2005","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2007.09.063_bib6","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0002-9440(10)61218-7","article-title":"Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality","volume":"167","author":"Firoved","year":"2005","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.vaccine.2007.09.063_bib7","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1172\/JCI17991","article-title":"Bacillus anthracis lethal toxin induces TNF-alpha-independent hypoxia-mediated toxicity in mice","volume":"112","author":"Moayeri","year":"2003","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.vaccine.2007.09.063_bib8","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.1128\/IAI.62.10.4432-4439.1994","article-title":"Anthrax edema toxin differentially regulates lipopolysaccharide-induced monocyte production of tumor necrosis factor alpha and interleukin-6 by increasing intracellular cyclic AMP","volume":"62","author":"Hoover","year":"1994","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2007.09.063_bib9","doi-asserted-by":"crossref","first-page":"8275","DOI":"10.1128\/IAI.73.12.8275-8281.2005","article-title":"Direct inhibition of T-lymphocyte activation by anthrax toxins in vivo","volume":"73","author":"Comer","year":"2005","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2007.09.063_bib10","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.4049\/jimmunol.174.8.4934","article-title":"Anthrax edema toxin cooperates with lethal toxin to impair cytokine secretion during infection of dendritic cells","volume":"174","author":"Tournier","year":"2005","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2007.09.063_bib11","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.it.2006.07.002","article-title":"Anthrax toxins: a paradigm of bacterial immune suppression","volume":"27","author":"Baldari","year":"2006","journal-title":"Trends Immunol"},{"issue":"32","key":"10.1016\/j.vaccine.2007.09.063_bib12","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1016\/S0264-410X(01)00234-1","article-title":"In vitro correlate of immunity in a rabbit model of inhalational anthrax","volume":"19","author":"Pitt","year":"2001","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2007.09.063_bib13","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1128\/IAI.65.12.5171-5175.1997","article-title":"Passive protection by polyclonal antibodies against Bacillus anthracis infection in guinea pigs","volume":"65","author":"Little","year":"1997","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2007.09.063_bib14","first-page":"144","article-title":"Studies on a protective antigen produced in vitro from Bacillus anthracis: medium and methods of production","volume":"35","author":"Belton","year":"1954","journal-title":"Br J Exp Pathol"},{"issue":"22","key":"10.1016\/j.vaccine.2007.09.063_bib15","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1001\/jama.282.22.2104","article-title":"Anthrax vaccine: evidence for safety and efficacy against inhalational anthrax","volume":"282","author":"Friedlander","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2007.09.063_bib16","series-title":"The anthrax vaccine. is it safe? does it work?","first-page":"265","year":"2002"},{"issue":"4","key":"10.1016\/j.vaccine.2007.09.063_bib17","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1128\/IAI.63.4.1369-1372.1995","article-title":"Protective immunity induced by Bacillus anthracis toxin-deficient strains","volume":"63","author":"Pezard","year":"1995","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2007.09.063_bib18","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.vaccine.2005.08.065","article-title":"Evidence for adjuvanticity of anthrax edema toxin","volume":"24","author":"Quesnel-Hellmann","year":"2006","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2007.09.063_bib19","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.vaccine.2005.08.056","article-title":"N-fragment of edema factor as a candidate antigen for immunization against anthrax","volume":"24","author":"Zeng","year":"2005","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2007.09.063_bib20","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1128\/IAI.69.7.4509-4515.2001","article-title":"Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein","volume":"69","author":"Price","year":"2001","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2007.09.063_bib21","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1128\/IAI.68.4.1781-1786.2000","article-title":"Role of toxin functional domains in anthrax pathogenesis","volume":"68","author":"Brossier","year":"2000","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2007.09.063_bib22","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1074\/jbc.M109997200","article-title":"Mapping the anthrax protective antigen binding site on the lethal and edema factors","volume":"277","author":"Lacy","year":"2002","journal-title":"J Biol Chem"},{"issue":"50","key":"10.1016\/j.vaccine.2007.09.063_bib23","doi-asserted-by":"crossref","first-page":"52473","DOI":"10.1074\/jbc.M409105200","article-title":"Involvement of domain II in toxicity of anthrax lethal factor","volume":"279","author":"Liang","year":"2004","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.vaccine.2007.09.063_bib24","doi-asserted-by":"crossref","first-page":"6532","DOI":"10.1128\/IAI.69.10.6532-6536.2001","article-title":"Purification of anthrax edema factor from Escherichia coli and identification of residues required for binding to anthrax protective antigen","volume":"69","author":"Kumar","year":"2001","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2007.09.063_bib25","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1006\/bbrc.2000.4099","article-title":"Involvement of residues 147VYYEIGK153 in binding of lethal factor to protective antigen of Bacillus anthracis","volume":"280","author":"Gupta","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.vaccine.2007.09.063_bib26","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.bbrc.2003.11.134","article-title":"Tyrosine-728 and glutamic acid-735 are essential for the metalloproteolytic activity of the lethal factor of Bacillus anthracis","volume":"313","author":"Tonello","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"10.1016\/j.vaccine.2007.09.063_bib27","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1128\/IAI.66.5.2374-2378.1998","article-title":"Lethal factor active-site mutations affect catalytic activity in vitro","volume":"66","author":"Hammond","year":"1998","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2007.09.063_bib28","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.abb.2005.11.016","article-title":"Kinetic characterization and ligand binding studies of His351 mutants of Bacillus anthracis adenylate cyclase","volume":"446","author":"Gupta","year":"2006","journal-title":"Arch Biochem Biophys"},{"issue":"5","key":"10.1016\/j.vaccine.2007.09.063_bib29","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/sj.emboj.7600574","article-title":"Calcium-independent calmodulin binding and two-metal-ion catalytic mechanism of anthrax edema factor","volume":"24","author":"Shen","year":"2005","journal-title":"EMBO J"},{"issue":"6","key":"10.1016\/j.vaccine.2007.09.063_bib30","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/j.1365-2958.1994.tb00500.x","article-title":"Anthrax toxin lethal factor contains a zinc metalloprotease consensus sequence which is required for lethal toxin activity","volume":"13","author":"Klimpel","year":"1994","journal-title":"Mol Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.09.063_bib31","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1006\/bbrc.2001.5337","article-title":"Rapid purification of recombinant anthrax-protective antigen under nondenaturing conditions","volume":"286","author":"Ahuja","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"issue":"31","key":"10.1016\/j.vaccine.2007.09.063_bib32","doi-asserted-by":"crossref","first-page":"18626","DOI":"10.1074\/jbc.270.31.18626","article-title":"Effect of anthrax toxin's lethal factor on ion channels formed by the protective antigen","volume":"270","author":"Zhao","year":"1995","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.vaccine.2007.09.063_bib33","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0898-6568(98)00041-2","article-title":"Activation of phospholipase C and protein kinase C is required for expression of anthrax lethal toxin cytotoxicity in J774A.1 cells","volume":"11","author":"Bhatnagar","year":"1999","journal-title":"Cell Signal"},{"issue":"2","key":"10.1016\/j.vaccine.2007.09.063_bib34","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1128\/IAI.74.2.1009-1015.2006","article-title":"Cytokine response and survival of mice immunized with an adenovirus expressing Bacillus anthracis protective antigen domain 4","volume":"74","author":"McConnell","year":"2006","journal-title":"Infect Immun"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2007.09.063_bib35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0014-5793(99)01502-1","article-title":"Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS\/IFNgamma-induced release of NO and TNFalpha","volume":"462","author":"Pellizzari","year":"1999","journal-title":"FEBS Lett"},{"issue":"3","key":"10.1016\/j.vaccine.2007.09.063_bib36","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1084\/jem.20041557","article-title":"Anthrax toxins suppress T lymphocyte activation by disrupting antigen receptor signaling","volume":"201","author":"Paccani","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2007.09.063_bib37","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1099\/00221287-31-2-329","article-title":"The three factors of anthrax toxin: their immunogenicity and lack of demonstrable enzymic activity","volume":"31","author":"Stanley","year":"1963","journal-title":"J Gen Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.09.063_bib38","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/BF00152686","article-title":"Recent advances in the development of an improved, human anthrax vaccine","volume":"4","author":"Ivins","year":"1988","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"10.1016\/j.vaccine.2007.09.063_bib39","doi-asserted-by":"crossref","first-page":"727","DOI":"10.4049\/jimmunol.96.4.727","article-title":"Immunologic studies of anthrax. IV. Evaluation of the immunogenicity of three components of anthrax toxin","volume":"96","author":"Mahlandt","year":"1966","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2007.09.063_bib40","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1128\/IAI.66.7.3447-3448.1998","article-title":"Study of immunization against anthrax with the purified recombinant protective antigen of Bacillus anthracis","volume":"66","author":"Singh","year":"1998","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2007.09.063_bib41","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1128\/IAI.71.6.3294-3301.2003","article-title":"Mutational analysis of the enzymatic domain of Clostridium difficile toxin B reveals novel inhibitors of the wild-type toxin","volume":"71","author":"Spyres","year":"2003","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2007.09.063_bib42","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0006-291X(03)01227-0","article-title":"Deletion mutants of protective antigen that inhibit anthrax toxin both in vitro and in vivo","volume":"307","author":"Ahuja","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.vaccine.2007.09.063_bib43","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.4049\/jimmunol.176.3.1776","article-title":"Bacillus anthracis edema toxin acts as an adjuvant for mucosal immune responses to nasally administered vaccine antigens","volume":"176","author":"Duverger","year":"2006","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.09.063_bib44","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1128\/IAI.74.1.794-797.2006","article-title":"Correlation between lethal toxin-neutralizing antibody titres and protection from intranasal challenge with Bacillus anthracis Ames strain spores in mice after transcutaneous immunization with recombinant anthrax protective antigen","volume":"74","author":"Peachman","year":"2006","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2007.09.063_bib45","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1128\/IAI.69.5.2888-2893.2001","article-title":"Search for correlates of protective immunity conferred by anthrax vaccine","volume":"69","author":"Reuveny","year":"2001","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07011231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07011231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T16:40:51Z","timestamp":1684082451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07011231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":45,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0264410X07011231"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.09.063","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}